The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

Alcohol doesn’t just impact the liver, it wreaks havoc on the entire digestive system. From inflamed gums and acid reflux to ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

which is also known as non-alcoholic steatohepatitis (NASH). The results come from Part 1 of the ESSENCE trial, which involved around 800 patients treated with semaglutide or placebo on top of ...

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and decreases inflammation.